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Ttc39c has been identified as a novel gene in skeletal muscle that is upregulated in response to 
neurogenic atrophy in mice. Quantitative PCR and Western blot analysis confirmed that Ttc39c is 
expressed in both proliferating and differentiated muscle cells. Furthermore, comparison of Ttc39c 
expression in undifferentiated and differentiated C2C12 cells demonstrated that Ttc39c levels peak 
in early differentiation, but decreases as cells become fully differentiated myotubes. The 
transcriptional regulation of Ttc39c was examined by cloning promoter fragments of the gene and 
fusing it with the SEAP reporter gene. The Ttc39c reporter gene constructs were transfected into 
muscle cells and confirmed to have significant transcriptional activity in cultured muscle cells and 
were also found to be transcriptionally repressed in response to ectopic expression of myogenic 
regulatory factors (MRF). Furthermore, conserved E-box elements in the proximal promoter 
region were identified, mutated, and analyzed for their role in the transcriptional regulation of 
Ttc39c expression. Mutation of the conserved E-box sequences reduced the activity of the Ttc39c 
reporter gene, suggesting that these elements are potentially necessary for full Ttc39c expression. 
To determine the sub-cellular location of Ttc39c in muscle cells, the Ttc39c cDNA was fused with 
the green fluorescent protein (GFP), expressed in muscle cells, and visualized by confocal 
microscopy revealing that Tct39c is localized to the cytoplasm of proliferating myoblasts and 
differentiating myotubes. Furthermore, Ttc39c appears to localize to the microtubule network and 
differentiating muscle cells developed elongated primary cilia in response to Ttc39c ectopic 
expression. Additionally, Ttc39c overexpression resulted in impaired muscle cell differentiation, 
attenuated Hedgehog and MAP Kinase signaling, and increased expression of IFT144, a 
component of the intraflagellar transport complex A involved in retrograde movement in primary 
cilia. Interestingly, Ttc39c knockdown also resulted in abrogated muscle cell differentiation and 
impaired Hedgehog and MAP Kinase signaling, but did not affect IFT144 expression levels. These 
results suggest that muscle cell differentiation is sensitive to aberrant Ttc39c expression, that 
Ttc39c is necessary for proper muscle cell differentiation, and that Ttc39c may participate in 





Chapter 1:  Background of Skeletal Muscle Atrophy, MuRF1, and Cell Signaling During 
Myogenesis 
Skeletal Muscle and Skeletal Muscle Atrophy 
Skeletal muscle is a dynamic tissue that, in humans, contains 50-75% of all body protein, conducts 
30-50% of whole-body protein turnover, and comprises around 40% of total body weight (Frontera 
and Ochala, 2014; Crist, 2016). The dynamic nature of skeletal muscle is exemplified by its ability 
to interpret a physiological response based off the reception and integration of external cues. The 
many important functions of skeletal muscle include generating force and power, posture 
maintenance, the production of heat for maintaining a physiologically appropriate core body 
temperature, and acting as storage for amino acids and carbohydrates (Frontera and Ochala, 2014; 
Crist, 2016). Skeletal muscle tissue mass is regulated based on an individual’s physiological needs, 
either by increasing in mass via protein synthesis (hypertrophy) or decreasing in mass via protein 
degradation (atrophy). Muscle mass is maintained by a balance between these two processes 
(McKinnell and Rudnicki, 2004). Skeletal muscle atrophy occurs when protein degradation 
outpaces protein synthesis, leading to the partial or complete wasting of skeletal muscle 
(McKinnell and Rudnicki, 2004; Bodine and Baehr, 2014). This process occurs for a number of 
reasons, including aging (sarcopenia), cancer, disuse, corticosteroid treatment, and denervation 
(Bodine, et al., 2001; Bonaldo and Sandri, 2013; Waddell et al., 2008). Increasing our 
understanding of this condition by studying the molecular and genetic mechanisms of skeletal 
muscle atrophy is important and may eventually provide new insights into alleviating or preventing 




Ubiquitin Proteasome System and E3 Ubiquitin Ligases 
The Ubiquitin Proteasome System (UPS) is the primary pathway by which protein is degraded 
during skeletal muscle atrophy. This pathway functions via E3 ubiquitin ligases, which 
ubiquitinate (tag) proteins for degradation by the 26S proteasome, which does so by hydrolyzing 
the peptide bonds of tagged proteins (Figure 1) (McNaught, et al., 2001; Ardley and Robinson, 
2005; Bodine and Baehr, 2014).  
 
Ubiquitination of proteins is accomplished by E3 ubiquitin ligases that covalently link a small 
ubiquitin protein to lysine residues on the target polypeptide. The ubiquitination modification 
requires three different proteins: the E1, E2, and E3 proteins. The E1 protein, called the ubiquitin 
activating enzyme, hydrolyzes an ATP molecule and adds adenylate to the ubiquitin molecule 
(McNaught, et al., 2001; Ardley and Robinson, 2005; Bodine and Baehr, 2014). The E2 protein, 
called the ubiquitin conjugating enzyme, then transfers the adenylated ubiquitin to one of its 
cysteine residues (McNaught, et al., 2001; Bodine and Baehr, 2014). Finally, the E3 ubiquitin 
ligase covalently attaches the ubiquitin to the target protein (McNaught, et al., 2001; Bodine and 
Baehr, 2014). While all three of the proteins work together to tag proteins for degradation, the E3 
is most important as it provides specificity by binding a unique subset of targets that will be 
ubiquitinated for degradation via the UPS (Ardley and Robinson, 2005; Bodine and Baehr, 2014).  
 
MuRF1 and MAFbx 
Two E3 ubiquitin ligases that have been identified as being upregulated in response to virtually all 
atrophy-inducing conditions are Muscle-RING Finger 1 (MuRF1) and Muscle Atrophy F-box 
(MAFbx) (Bodine, et al., 2001). In the study conducted by Bodine et al., rats subjected to  
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Figure 1. A schematic of the Ubiquitin Proteasome System. The ubiquitin activating enzyme (E1), the ubiquitin 
conjugating enzyme (E2), and the ubiquitin ligase (E3) work in concert to ubiquitinate proteins for degradation via 
the 26S proteasome (Adapted from Dodd, 2011). 
 
immobilization, denervation, and handlimb suspension had their medial gastrocnemius muscle 
isolated and analyzed to identify genes that were differentially expressed under these atrophy-
inducing conditions. Of the many genes identified, only MuRF1 and MAFbx were shown to be 
upregulated in response to all three conditions (Fig. 2). Additionally, mice with MuRF1 or MAFbx 
knocked out exhibited atrophy resistance when compared to wild-type mice. It is clear that MuRF1 
and MAFbx are key regulators in skeletal muscle atrophy, but the exact molecular mechanisms are 
not well understood and only a small number of potential targets have been identified to date, such 
as myosin-binding protein C (MyBP-C), myosin light chains 1 and 2 (MyLC1 and MyLC2), and 
myosin heavy chain (MyHC) (Bodine and Baehr, 2014). A lack of clear protein targets of MuRF1 
and MAFbx has led to additional questions about their role in the muscle atrophy cascade and calls 






Figure 2. Northern blot displaying the mRNA expression profiles of MuRF1 and MAFbx during three atrophy-
inducing conditions: immobilization, denervation, and hindlimb suspension. Increased expression of both genes is 
observed at day 1 and reaches maximum expression at day 3. (Bodine, et al., 2001). 
 
MuRF1 as a transcriptional regulator  
MuRF1 has been hypothesized to function as an E3 ubiquitin ligase based on its three functional 
domains, although few targets have been identified (Bodine and Baehr, 2014). The RING domain 
is a zinc finger protein domain that contains cysteine and histidine residues that interact with zinc 
ions. The RING domain is believed to be required for E3 enzyme activity and is predicted to 
perform the catalytic ligase activity of MuRF1 (Furlow et al., 2013; Bodine and Baehr, 2014). The 
two other domains are the B-box and B-box c-terminal (Bbc) domains, which may aid in the 
binding of DNA and/or other proteins by forming additional zinc finger structures (Mrosek et al., 
2008). Furthermore, MuRF1 has an acidic c-terminus that currently has no known function, 
although it is hypothesized that acidic carboxyl termini may aid in the subcellular localization of 
proteins (McElhinny, et al., 2002; Hohlfeld et al., 2006).  
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A study published in 2013 by Furlow et al. suggested that the role of MuRF1 in skeletal muscle 
atrophy is likely more complex than initially believed. Two populations of 4 to 6 month old female 
mice consisting of either wild-type (WT) and MuRF1 knock-out (KO) littermates were compared 
under control and atrophy conditions. The KO mice were created by inserting a β-galactosidase-
encoding LacZ cassette in the MuRF1 gene (Furlow et al., 2013). The design of the MuRF1 
knockout mouse preserved the endogenous promoter, which results in β-galactosidase being 
expressed as a reporter MuRF1 locus activity in the MuRF1-null animals. This system allowed 
researchers to quantitatively assess when the MuRF1 endogenous promoter was active even 
though there was no functional MuRF1 being produced in the KO animals. Following denervation, 
the gastrocnemius muscle was isolated, and a genome-wide microarray was performed to identify 
differences in gene expression in response to neurogenic atrophy at two different time points: 3 
days and 14 days post-denervation (Furlow et al., 2013). In the WT mice, MuRF1 expression 
increased at day 3, but returned to baseline levels by day 14. In the MuRF1-KO mice, however, β-
galactosidase levels were elevated at day 3 and remained elevated at day 14 (Fig. 3; Furlow et al., 














Figure 3. Transcriptional activity of the MuRF1 locus in WT and MuRF1 KO mice postdenervation. (A) Denervated 
WT mice showed an increase in MuRF1 gene expression at day 3 (3D), but a return to baseline at day 14 (14D) post-
denervation. (B) Denervated KO mouse showed at increase in β-galactosidase expression, which is under the control 
of the MuRF1 promoter, at day 3 and expression remained elevated at day 14 post-denervation (Furlow, et al., 2013). 
 



















































Furthermore, MAFbx expression was also found to be affected by MuRF1 expression levels as 
well. In WT mice, MAFbx expression was increased by day 3, but returned to baseline by day 14, 
while in MuRF1 KO mice MAFbx expression remained elevated at both day 3 and day 14 post-
denervation (Fig, 4; Furlow et al., 2013). This suggests that MuRF1 may also negatively affect the 






























































Figure 4. Transcriptional activity of MAFbx in WT and MuRF1 KO mice post-denervation. (A) Denervated WT mice 
showed an increase in MAFbx gene expression at day 3 (3D), but returned to baseline by day 14 (14D) post-
denervation. (B) Denervated MuRF1 KO mice showed an increase in MAFbx gene expression at day 3 that remained 
elevated at day 14 post-denervation (Furlow, et al., 2013). 
 
In addition to the differences in MuRF1 and MAFBx expression, a subset of genes showed 
differential expression when comparing the WT and KO cohorts following denervation (Furlow et 
al., 2015). Many of the differentially expressed genes have been shown to have a range of potential 
functions, including roles in muscle structure and function, signal transduction cascades, and 
metabolic pathways. Among the genes believed to be important in the regulation of muscle cell 
signaling cascades is one gene of particular interest: Tetratricopeptide 39c (Ttc39c). 
 
Overview of Tetratricopeptide 39c 
Ttc39c is a gene that encodes for a protein that contains several putative tetratricopeptide repeat 
(TPR) domains, a structural motif which has been shown to facilitate protein-protein interactions 
(D’Andrea and Regan, 2003). Other proteins that contain these domains have been shown to 
function in cell signaling pathways, apoptosis, and cell cycle regulation (Blatch and Lassle, 1999). 
Ttc39c has been shown to be critical for proper formation of motile and non-motile cilia in 
zebrafish, although its exact function remains unclear (Xu et al., 2015). Zebrafish embryos with 
Ttc39c knocked down exhibited several ciliopathic phenotypes, including abnormal body 
curvature, incorrect left-right patterning of organs, hydrocephalus, and abnormal otolith 
development (Xu et al., 2015). This same study also observed via co-immunoprecipitation that 
Ttc39c had weak interactions with two proteins, IFT139 and IFT144, which are part of the IFT A 
complex that is responsible for retrograde intraflagellar transport in cilia (Xu et al., 2015). 
Importantly, while fully differentiated skeletal muscle fibers do not possess motile cilia, 
proliferating and differentiating muscle cells do possess primary cilia (Fu, et al., 2014).  
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The Primary Cilia and Cellular Signaling in Muscle Development 
Primary cilia are non-motile, hair-like projections found on the surface of many cell types and 
have been shown to coordinate cell signaling during development and tissue homeostasis (Prevo 
et al., 2017; Satir et al., 2010). Primary cilia structure consists of nine microtubule doublets that 
are derived from a basal body, a transition zone which separates the cytoplasm from the cilium 
interior, and the ciliary membrane (Prevo et al., 2017; Satir et al., 2010, Bangs and Anderson, 
2017). Intraflagellar transport (IFT) complexes are crucial for proper cargo transport up and down 
the ciliary axoneme, with IFT-A performing retrograde transport via dynein motors and IFT-B 
performing anterograde transport via kinesin motors (Fig. 5) (Bangs and Anderson, 2017; Prevo 
et al., 2017; Goetz and Anderson, 2010; Satir et al., 2010. Yuan and Yang, 2015). A complex of 
Bardet-Biedl syndrome (BBS) proteins comprising the BBSome are also required for proper IFT 
(Prevo, et al., 2017; Ye, et al., 2018; Liu and Lechtreck, 2018).  Interestingly, primary cilia have 
been shown to be critical for proper Hedgehog (Hh) signaling, a pathway important for organ 
development and intercellular communication (Bangs and Anderson, 2017), as well as Wingless 
(Wnt), Notch, and mitogen-activated protein kinase (MAPK) signaling pathways (Prevo, et al., 
2017; Satir, et al., 2010). 
 
Properly regulated signaling, including the Hh pathway, is crucial for skeletal muscle development 
(Bentzinger, et al., 2012; Mok and Sweetman, 2011; Bismuth and Relaix, 2010; Fu, et al., 2014). 
Some studies have found that increased Hh signaling leads to attenuated myotube formation due 
to increased proliferation of satellite cells and inhibition of MyoD, a Myogenic Regulatory Factor 
(MRF), to activate the transcription of muscle-specific genes (Koleva et al., 2005; Gerber et al., 
2007). Others have observed that an increase in Hh signaling actually increases myotube formation 
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of myoblasts already committed to differentiation (Duprez et al., 1998; Li, et al., 2004). Regardless 
of the exact role that Hh signaling plays in muscle cell differentiation, it is well established that 
primary cilia are critical for proper Hh signaling (Fu et al., 2014; Bangs and Anderson, 2017; Goetz 
and Anderson, 2010; Satir et al., 2010). Another study has shown that blocking the formation of 
primary cilia in C2C12 mouse myoblasts by inhibiting the expression of proteins crucial for cilia 
formation resulted in aberrant Hh signaling, leading to a decrease in MRF expression and myoblast 
differentiation (Fu et al., 2014). This same study also found that primary cilia formation peaks in 
the transition between proliferation and differentiation of primary mouse myoblasts (Fu et al., 
2014). 
 
Figure 5. Primary cilia structure and intraflagellar (IFT) transport. IFT-A and IFT-B complexes, along with the 
BBSome complex, transport cargo up and down the ciliary axoneme that originates from the cell’s basal body. IFT-A 
conducts retrograde transport via dynein motors, while IFT-B conducts anterograde via kinesin motors. (Adapted from 
Yuan and Yang, 2015) 
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In addition to Hh signaling, several receptor tyrosine kinases (RTKs) have been shown to localize 
within the primary cilium, including PDGFRa, EGFR, IGF-1R, and FGFR (Christensen et al., 
2012). Upon binding of the appropriate growth factor, these receptors will activate several 
pathways such as mitogen-activated protein kinase (MAPK) pathways, including the MEK1/2-
ERK1/2 pathway, which is known to control cell proliferation, migration, and cell differentiation 
(Christensen et al., 2012). ERK1/2 signaling is required for proper skeletal muscle development 
and has a nuanced effect on differentiating myoblasts (Knight and Kothary, 2011). ERK1/2 activity 
is critical for myoblast proliferation and preventing premature differentiation (Kook et al., 2007; 
Knight and Kothary, 2011), but the pathway activity decreases as myoblasts differentiate (Knight 
and Kothary, 2011). Furthermore, it has been observed that when ERK1/2 signaling activity is 
sustained, myoblast differentiation is inhibited (Sarbassov et al., 1997; Winter and Arnold, 2000; 
Rodriguez, et al., 2014). Even more interesting, ERK1/2 activity has been shown to increase again 
during terminal differentiation and has been found to be critical for proper myocyte fusion and 
survival (Adi et al., 2002; Bennett and Tonks, 1997; Sarbassov et al., 1997; Gredinger et al., 1998). 
The reliance of myoblasts on these disparate signaling pathways for proper differentiation displays 
the importance of proper regulation of signal transduction cascades, which appear to depend on 
proper assembly and function of the primary cilia.  
 
Taken together, evidence linking Ttc39c to proper cilia formation and the role of primary cilia in 
skeletal muscle cell differentiation via cellular signaling cascades suggests a possible function of 
Ttc39c in muscle cell primary cilium formation and function that in-turn is crucial for proper 
differentiation of myoblasts into functional skeletal muscle tissue. 
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Chapter 2: Material and Methods, Results, and Discussion 
Materials and Methods 
Cell Culture 
Cell culture was performed as previously described (Waddell et al., 2015). Briefly, the C2C12 
immortalized mouse myoblast cell line (CRL-1772) was obtained from the American Type Culture 
Collection (Manassas, VA) and maintained in DMEM (Life Technologies, Grand Island, NY) 
supplemented with 10% Fetal Bovine Serum (FBS) (GE Healthcare HyClone Laboratories, Logan, 
UT), non-essential amino acids, 1X Penicillin/Streptomycin and Gentamicin (all from Life 
Technologies, Grand Island, NY) and grown at 37˚C in a humidified chamber at 5% CO2. Cells 
were switched to DMEM supplemented with 2% serum, non-essential amino acids, 
Penicillin/Streptomycin and Gentamicin in order to induce myoblast to myotube differentiation.  
 
RNA isolation and cDNA synthesis  
Total RNA was isolated from C2C12 myoblast cells using the RNeasy Mini Kit (Qiagen, Valencia, 
CA) according to the manufacturer’s protocol. Purified total RNA (0.75-1.5µg) was reverse-
transcribed using Oligo-dT primers and Moloney Murine Leukemia Virus (M-MLV) Reverse 
Transcriptase according to the manufacturer’s protocol (Life Technologies, Grand Island, NY).  
 
Amplification and cloning of the full-length Ttc39c cDNA 
For the amplification of Ttc39c cDNA, gene-specific primer pairs were designed (Table 1.) using 
the gene sequence from Mus musculus (Ttc39c, GenBank accession number: NM_028341). PCR 
was performed according to the manufacturer’s protocol (Life Technologies, Grand Island, NY) 
using Taq DNA polymerase, gene specific primer pairs, and DNA template prepared by reverse 
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transcription of RNA isolated from C2C12 cells as described in section 2.2. Amplicons were cloned 
into the pGEM-T Easy vector (Promega, Madison, WI) according the manufacturer’s protocol and 
sequenced using the Big Dye Sanger terminator sequencing method (Eurofins MWG Operon, 
Huntsville, AL) to confirm amplification of the expected target and the absence of mutations. The 
Ttc39c cDNA was sub-cloned into the EcoRI restriction site of pcDNA3.1 (+) (Life Technologies, 
Grand Island, NY) and sequenced to confirm correct orientation and lack of mutations. The Ttc39c 
cDNA was also sub-cloned into the EcoRI restriction site of the pEGFP-C3 and pCS2+MT 
expression plasmids (Clontech, Mountain View, CA) and sequenced to confirm correct orientation 
















Table 1. List of primers used in this study. 










































Promoter cloning of the Ttc39c gene 
For the amplification of the proximal regulatory region of Ttc39c, genomic DNA was isolated 
from C2C12 cells using the DNeasy Blood and Tissue Kit (Qiagen, Valencia, CA) according to the 
manufacturer’s protocol. PCR was performed using Ttc39c promoter region-specific primer pairs 
(Table 1.) designed using mouse genomic sequences obtained from the Ensembl database 
(www.ensembl.org). PCR reactions were performed using 1µg of genomic DNA and Taq DNA 
polymerase according to the manufacturer’s protocol (Life Technologies, Grand Island, NY). The 
PCR amplicons were cloned into the pGEM-T vector (Promega, Madison, WI) according to the 
manufacturer’s protocol and sequenced to confirm amplification of the predicted target region and 
the absence of mutations. The Ttc39c promoter fragments were each sub-cloned into the NheI and 
Hind III sites of the pSEAP2-Basic reporter plasmid (Clontech, Mountain View, CA) to create the 
pSEAP-Ttc39c-Pro500, pSEAP-Ttc39c-Pro1000 and pSEAP-Ttc39c-Pro2000 reporter plasmids 
and sequenced to confirm correct orientation.    
 
Site-directed Mutagenesis 
The conserved E-box enhancer sequences located in the regulatory region of Ttc39c were mutated 
using the primer pairs listed in Table 1. The QuikChange II Site-Directed Mutagenesis protocol 
utilizing PfuTurbo DNA polymerase was performed according to the manufacturer’s protocol 
(Agilent Technologies, Santa Clara, CA). The mutagenesis PCR reactions were digested with Dpn 
I (New England BioLabs, Ipswich, MA) and then transformed into sub-cloning efficiency 
competent cells (Life Technologies, Grand Island, NY). Clones were isolated and plasmids were 




C2C12 myoblasts cells were plated into 12-well plates at a density of 50,000-75,000 cells/well and 
cultured overnight. Transfections were performed using TurboFect Transfection Reagent (Thermo 
Scientific, Rockford, IL) according to the manufacturer’s protocol. Briefly, media was changed 
approximately 1-2 hours prior to transfection and 1µg of total DNA (250 ng/well of reporter 
plasmid, 125 ng/well of internal control plasmid, 125-250 ng/well of expression plasmids and 
empty pBluescript vector as filler DNA to 1 µg/well) was allowed to complex with the TurboFect 
transfection reagent for 20-30 minutes prior to overlaying the cells. Cells were incubated overnight 
with the TurboFect:DNA complexes. Cells were switched to differentiation media (2% serum) 24 
hours post-transfection and incubated for an additional 24-72 hours prior to performing reporter 
assays. 
 
Reporter gene assays 
In order to monitor reporter gene activity, culture media was sampled at 24-72 hours following the 
switch to differentiation media and analyzed for SEAP activity using the Phospha-Light SEAP 
Reporter Gene Assay System according to the manufacturer’s protocol (Life Technologies, Grand 
Island, NY). Glow luminescence levels were detected using a Synergy 2 microplate reader set for 
an endpoint read with a 2 second integration time. At the end of the assay, cells were lysed using 
Passive Lysis Buffer (Promega, Madison, WI), homogenates were cleared by centrifugation and 
analyzed for β-galactosidase (β-gal) activity. SEAP activity numbers were divided by β-gal 




Bioinformatic analysis of Ttc39c 
The nucleotide sequence corresponding to the regulatory regions of mouse, rat and human Ttc39c 
(Ensembl Transcript ID: ENSMUST00000025294.7, NSRNOT00000091424.1, and 
ENST00000317571.7, respectively) from -2000 through the first exon were downloaded from the 
Ensembl database (www.ensembl.org), aligned using the ClustalW2 alignment tool on the EMBL 
website (http://www.ebi.ac.uk/Tools/msa/clustalw2/), followed by Boxshade analysis of the 
ClustalW2 alignment output data (http://www.ch.embnet.org/software/BOX_form.html). The 
amino acid sequences for mouse Ttc39c were downloaded from the Ensembl database and aligned 
and shaded as described for the nucleotide sequences above.  
 
Quantitative PCR  
Total RNA was isolated from proliferating and differentiated C2C12 cells as described in section 
2.2. Purified total RNA (1.0µg) was reverse-transcribed using the iScript cDNA Synthesis Kit 
according to the manufacturer’s protocol (Bio-Rad, Hercules, CA). The cDNA was them amplified 
using the iTaq Universal SYBR Green Reaction Supermix according the manufacturer’s protocol 
(Bio-Rad, Hercules, CA) and quantitative analysis of Ttc39c expression was analyzed using the 
CFX Connect Real Time PCR Detection System (Bio-Rad, Hercules, CA). Each condition was 
performed in biological triplicates, each individual biological replicate was used for cDNA 
synthesis in duplicate, and each cDNA synthesis replicate was performed in technical triplicates 
(3 biological replicates x 2 cDNA synthesis replicates x 3 technical replicates = 18 individual reads 
per biological sample) and the experiment was repeated at least once. Relative Ttc39c gene 
expression was calculated using the 2-ΔΔCT Livak method and GAPDH as the reference gene.      
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Protein purification and Western blot analysis 
C2C12 cells were differentiated over a 10 day time course by plating cells into 10cm culture dishes 
and maintaining them in proliferation media (DMEM + 10% serum) for 2 days followed by a 
switch to differentiation media (DMEM + 2% serum) at 2 days post-plating. The time course 
consisted of harvesting cells grown in proliferation media for 1 and 2 days, as well as, cells grown 
for 2 days in proliferation media followed by continued culturing for 1, 3, 5, 7, and 10 days in 
differentiation media. Harvested cells were spun down and stored at -80˚C until cell lysis and 
protein purification was performed.  
 
Ttc39c was exogenously expressed in C2C12 cells that were plated into 10cm culture dishes and 
transfected with the pcDNA3.1-Ttc39c expression plasmid 24 hours post-plating. The transfected 
cells were differentiated over a 5 day time course by maintaining them in proliferation media 
(DMEM + 10% serum) for 2 days followed by a switch to differentiation media (DMEM + 2% 
serum) at 2 days post-plating. The time course consisted of harvesting cells grown in proliferation 
media for 2 days, as well as, cells grown for 2 days in proliferation media followed by continued 
culturing for 1, 2, 3, 4 and 5 days in differentiation media. Harvested cells were spun down and 
stored at -80˚C until cell lysis and protein purification was performed. 
 
Harvested cells were lysed on ice for 30 minutes in ULB(+) (50mM Tris, pH 7.5, 150mM NaCl, 
50mM NaF, 0.5% NP-40, 1mM PMSF, 1mM DTT, 10mM β-glycerophosphate, 2mM sodium 
molbydate and a protease inhibitor cocktail). Cell lysates were cleared by centrifugation and 
protein concentrations were quantified using the Quick Start Bradford 1X Dye Reagent (Bio-Rad, 
Hercules, CA) according to the manufacturer’s protocol.   
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Western blot analysis was performed by separating 25-100µg of total protein on a SDS-PAGE gel 
and then transferring the separated proteins overnight to Immobilon-P PVDF membrane (EMD 
Millipore, Billerica, MA). The membrane was Ponceau S stained to confirm equal protein loading 
and then blocked in blocking solution (5% w/v dry milk dissolved in Tris-buffered Saline (TBS) 
with 0.05% Tween-20). Blots were probed with anti-Ttc39c (G-6, Santa Cruz Biotechnology), 
anti-Myosin Heavy Chain (MYH1/2/4/6) (F59, Santa Cruz Biotechnology, Dallas, TX), anti-
myogenin (F5D, Santa Cruz Biotechnology, Dallas, TX), anti-MyoD (5.8A, Santa Cruz 
Biotechnology, Dallas, TX), anti-p-ERK (E-4, Santa Cruz Biotechnology, Dallas, TX), anti-ERK 
(K-23, Santa Cruz Biotechnology, Dallas, TX), anti-IFT144 (ProteinTech, Rosemont, IL), anti-
IFT88 (ProteinTech, Rosemont, IL), anti-acetylated tubulin (ProteinTech, Rosemont, IL), anti-
Gli2 (ProteinTech, Rosemont, IL), or anti-α-tubulin (DM1A, Santa Cruz Biotechnology) primary 
antibodies followed by incubation with a species appropriate HRP-conjugated secondary antibody 
(Santa Cruz Biotechnology, Dallas, TX) and developed using ECL Western Blotting Substrate 
(Pierce/Thermo Scientific, Rockford, IL). Blots were stripped by incubating at room temperature 
for 10-15 minutes in Stripping Buffer (6M Guanidine Hydrochloride, 20mM Tris, pH 7.5, 0.2% 
Igepal CA-630, and 0.1M DTT), washed, and then blocked, re-probed and imaged as described 
above.   
 
Confocal Fluorescence Microscopy 
C2C12 cells were plated into Cellvis 35mm glass bottom dishes with 20mm bottom well and 
transfected ~24 hours post-plating with pEGFP-C1 empty vector or pEGFP-Ttc39c complexed 
with TurboFect Transfection Reagent (Thermo Scientific, Rockford, IL) according to the 
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manufacturer’s protocol. Cells were washed 2X with PBS ~24 hours post-transfection, fixed with 
4% paraformaldehyde in 0.1M sodium cacodylate, pH 7.6, stained with DRAQ5 far-red 
fluorescent DNA dye (Biostatus, Leicestershire, UK) and mounted with VECTASHIELD HardSet 
Mounting Medium (Vector Laboratories, Burlingame, CA). All images shown were taken using 
an Olympus Fluoview FV-1000 confocal fluorescent microscope with either a Super Apochromat 
UPLSAPO 20X objective or a Super Apochromat UPLSAPO 60XW objective. The GFP and 
DRAQ5 images were merged using open access ImageJ software with the Open Microscopy 
Environment Bio-Formats software plugin tool.  
 
siRNA Knockdown of Ttc39c 
The murine Ttc39c transcript (GenBank accession number: NM_028341) was analyzed using the 
Whitehead Institute siRNA design tool (http://sirna.wi.mit.edu/) and two siRNA targeting 
sequences were selected. The sequences were used in the creation of two sets of complimentary 
oligonucleotides (Table 1.) that were then annealed together and cloned into the Bgl II and Hind 
III sites of the pSuper-Basic plasmid according the manufacturer’s protocol (Oligoengine, Seattle, 
WA). Recombinant plasmids were sequenced to confirm proper orientation and absence of 
mutations. C2C12 cells were then transfected with the pSuper-Ttc39c-siRNA-2 or pSuper-Ttc39c-
siRNA-3 plasmid as described in section 2.6, cells were harvested 24-48 hours post-transfection, 







Data are presented as the mean ± standard deviation (SD). Statistical analysis was conducted using 
a two-tailed t-test and a difference was considered statistically significant at a P value < 0.05. 
 
Results 
Ttc39c is induced during skeletal muscle atrophy and is differentially expressed in MuRF1-null 
mice. 
An Illumina mouse-6 v1.1 expression beadchip array was performed on RNA isolated from triceps 
surae (TS) muscle from mice undergoing neurogenic atrophy (i.e. denervation) as previously 
described (Furlow et al., 2013). Deeper analysis of the data SubSeries (GEO: GSE44205) 
deposited as part of a SuperSeries (GEO: GSE44259) submitted to the NCBI Gene Expression 
Omnibus (GEO) revealed a number of genes that have not previously been described in skeletal 
muscle and show differential expression patterns in response to denervation-induced skeletal 
muscle atrophy. Ttc39c, which was originally identified as a Riken gene (2810439F02RIK) in the 
Illumina beadchip array, showed relatively low basal expression in control muscle tissue, but was 
induced significantly in response to neurogenic atrophy at 3 days and 14 days post-denervation 
(Fig. 6A). In contrast, neurogenic atrophy had no effect on Ttc39c expression in muscle tissue 
isolated from MuRF1-null mice at 3 days or 14 days post-denervation (Fig. 6B). 
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Figure 6. Ttc39c is induced during neurogenic skeletal muscle atrophy and is expressed in muscle cells. Whole 
genome expression analysis was conducted on triceps surae muscle from (A) wild-type (WT) and (B) MuRF1-null 
(KO) control (CON) mice after 3 days (3D) and 14 days (14D) of denervation (DEN). Ttc39c expression (array address 
1410725) increased significantly at both 3 and 14 days of denervation in wild-type (WT) animals, but not in MuRF1-
null animals.  Each condition represents the average expression from three animals and error bars represent ± SD. 
White bars, controls; black bars, DEN. Significant difference between denervated mice and control mice in the same 












Ttc39c expression is highest during early skeletal muscle cell differentiation. 
Ttc39c is located on chromosome 18 in M. musculus and is predicted to have two alternative 
transcripts (identified in this manuscript as alternative transcript 1 (AT1) and alternative transcript 
2 (AT2) that each consist of 14 exons. The AT1 isoform consists of 14 coding exons (Fig. 7A), 
while the AT2 isoform consists of 13 coding exons and one non-coding exon (Fig. 7B). To confirm 
that Ttc39c is expressed endogenously at the RNA level in muscle cells, qPCR was performed 
using RNA isolated from proliferating myoblasts and myotubes at early and late stages of 
differentiation. The results demonstrate that Ttc39c expression is elevated in early differentiation 











Figure 7. Schematics for the alternative transcripts of Ttc39c and endogenous expression profile of Ttc39c in C2C12 
myoblasts. Schematics of the (A) Ttc39c-AT1 and (B) Ttc39c-AT2 alternative transcripts of the Ttc39 gene locus in 
mouse. Darkened rectangles represent exons containing translated region, open rectangles represent exons 
containing the untranslated regions and the lines connecting the rectangles represent introns. The arrows signify the 
location of the qPCR primers used to quantify the expression of the Ttc39c transcript. (C)  Ttc39c increases in 
expression in early differentiation and then decreases as C2C12 myoblasts differentiate. qPCR was performed on 
RNA isolated from proliferating (P) and differentiated (D) C2C12 cells harvested over a 7 day differentiation time 
course. Cells were maintained in proliferation media (10% serum) and harvested 2 days post-plating (PD2) and the 
remaining cells were then switched to differentiation media (2% serum) and harvested at 2 (DD2) and 7 (DD7) days 
post-media change. Ttc39c expression was calculated using the ΔΔCT method with normalization to GAPDH 
expression. Significant difference between Ttc39c expression at DD2 compared PD2, (**: P < 0.01) 
 
To assess the effectiveness of a commercially available primary mouse monoclonal Ttc39c 
antibody (G6, Santa Cruz Biotechnology used at 1:1000 dilution) to detect mouse Ttc39c, 293T 
cells were transfected with expression plasmids that contained untagged murine Ttc39c, GFP-
tagged Ttc39c and 6X-myc-tagged Ttc39c. Cells transfected with the mouse Ttc39c expression 
plasmids showed elevated levels of Ttc39c protein and also demonstrated a doublet that likely 
represents two alternative protein isoforms (Fig. 8). C2C12 cells were differentiated and harvested 
over a 10 day time course and cell lysates were analyzed by Western blotting for endogenous 
Ttc39c protein expression levels (Fig. 9). Ttc39c protein levels peaked during late proliferation 
and early differentiation and then decreased by day 3 of differentiation. To monitor the 
differentiation status of C2C12 cells over the differentiation time course, blots were also probed 
using a mouse monoclonal myosin heavy chain antibody (1:500 dilution). Myosin heavy chain 
increases as C2C12 cells begin to differentiate from myoblasts to myotubes and peaks and stabilizes 
at about differentiation day 2 (Fig. 9). To confirm equal protein loading, the blots were also probed 




Figure 8. Validation of the Ttc39c mouse monoclonal antibody. Western blot analysis of ectopically expressed Ttc39c 
in 293T cells. 293T cells were transiently transfected with pcDNA3.1-Ttc39c, pCS2-6X-myc-Ttc39c, or pEGFP-
Ttc39c. The gel was loaded with 25ug of protein lysate isolated from control cells and pcDNA3.1-Ttc39c transfected 
cells and three concentrations (25 µg, 50 µg and 75 µg) of protein lysate from cells transfected with pCS2-6X-myc-
Ttc39c or pEGFP-Ttc39c were analyzed by Western blot.   
 
 
Figure 9. Ttc39c protein expression profile in C2C12 myoblasts. Western blot analysis was performed using an 
antibody against Ttc39c on protein homogenates isolated from proliferating (P) and differentiated (D) C2C12 cells 
harvested over a 10 day differentiation time course. Cells were maintained in proliferation media (10% serum) and 
harvested 1 and 2 days post-plating and the remaining cells were then switched to differentiation media (2% serum) 
and harvested at 1, 3, 5, 7 and 10 days post-media change. Myosin Heavy Chain (MyHC) was analyzed as a marker 
for differentiation and α-tubulin was analyzed to confirm equal protein loading. 
 
Identified putative functional domains of Ttc39c possibly facilitate protein-protein interactions. 
Mouse Ttc39c has two putative protein isoforms that are 580 amino acids (Ttc39c-580) or 522 
amino acids (Ttc39c-522) in length and have predicted molecular weights of ~65.5kDA and 
~59kDA, respectively. These two Ttc39c protein isoforms are validated in human and are 
predicted in mouse and are produced by the use of alternative start codons, which are indicated 
with an asterisk and highlighted in blue in the protein sequence alignment (Fig. 10). The Ttc39c 
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amino acid sequence is highly conserved from rodents to humans, with human Ttc39c sharing 94% 
identity with mouse and rat Ttc39c. Using the SMART database and the NCBI Conserved Domain 
Database (CDD), both Ttc39c isoforms are predicted to have a large domain of unknown function 
(DUF) spanning amino acids 31-495 that includes at least 4 tetratricopeptide repeat (TPR) domains 
(highlighted in red) (Fig. 10). The TPR domain has been shown to play an important role in 
protein-protein interactions and is proposed to be important for proteins that act as scaffolds for 




Figure 10. Protein sequence alignment of Ttc39c in mouse, rat, and human. Sequences of the mouse, rat and human 
Ttc39c protein were downloaded from the Ensembl database and aligned using the ClustalW2 algorithm. Approximate 
positions of the putative Tetratricopeptide Repeat (TPR) domains are highlighted in red in the alignment. The 
alternative start codons for Ttc39c-580 and Ttc39c-522 are highlighted in blue and indicated with an asterisk. The 
gene structure schematic images were downloaded from the Ensembl database (www.ensembl.org).      
 
Cloning and analysis of the proximal regulatory regions of Ttc39c alternative transcripts. 
Transcription initiation of the Ttc39c locus is predicted to occur from two alternative regions 
resulting in a two different transcripts with alternative first exons (Fig. 7A and Fig 7B). In order 
to assess the level of conservation between the common promoter regions of mouse, rat and human 
Ttc39c-AT1 and mouse and rat (Tct39c-AT2) and to identify potential transcriptional regulatory 
elements, the genomic sequences corresponding to the regulatory regions of these two alternative 
transcripts for mouse, rat and human were aligned (Fig. 11A and 12A). Several putative enhancer 
elements were identified, including a conserved E-box sequence in each putative promoter, and 
are indicated in the promoter schematics with an asterisk (Fig. 11A and 12A). In addition to the 
conserved E-box, the proximal regulatory region of Ttc39c-AT1 contains a FoxO consensus 
element and TFIIB binding element, while the proximal regulatory region of Ttc39c-AT2 contains 
a putative Elk1 consensus element, a consensus AP-1 element, a Runx1 element and a TFIIB 
binding element (Fig. 11A and 12A).  
 
To confirm that the regulatory regions of both alternative transcripts possess transcriptional 
activity, 500, 1000 and 2000 bp fragments of the proximal regulatory regions of each transcript 
was cloned using the primer pairs listed in Table 1. The promoter fragments were fused with the 
secreted alkaline phosphatase (SEAP) reporter gene to create the pSEAP-Ttc39c-AT1-Pro500, 
pSEAP-Ttc39c-AT1-Pro1000, pSEAP-Ttc39c-AT1-Pro2000, pSEAP-Ttc39c-AT2-Pro500, 
pSEAP-Ttc39c-AT2-Pro1000, and pSEAP-Ttc39c-AT2-Pro2000 reporter plasmids. C2C12 mouse 
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myoblast cells were transiently transfected with the Ttc39c-AT1 and Ttc39c-AT2 reporter plasmids 
and SEAP activity levels were analyzed 48-72 hours following the switch to differentiation media 
and compared to SEAP activity levels from cells transfected with the empty pSEAP2-Basic 
plasmid. The Ttc39c-AT1 and Ttc39c-AT2 reporter plasmids each showed robust transcriptional 
activity and had significantly higher activity compared to the empty reporter plasmid alone (Fig. 













Figure 11. Schematic, sequence alignment, and analysis of the Ttc39c-AT1alternative transcript promoter region. 
Promoter sequences from mouse, rat, and human Ttc39c-AT1 (2000 base pairs upstream of the start of the 
transcription start site (+1) through the first exon) were downloaded from the Ensembl database (www.ensembl.org) 
and aligned using the ClustalW algorithm. Approximate positions of putative transcription factor binding sites are 
indicated in the schematic of the (A) Ttc39c-AT1 regulatory region at the top. Putative TFIIB Response Element 
(BRE) 5’-(G/C)(G/C(G/A)CGCC-3’ (shaded trapezoid), predicted FoxO binding element 5’-(G/A)TAAA(T/C)AA-
3” (checkered diamond), and putative consensus E-box elements 5’-CANNTG-3’ (dotted triangle) are indicated. N 
represents any nucleotide. Conserved nucleotides are highlighted in black, transitions are highlighted in gray and 
transversions are highlighted in white. The black arrow indicates the position of the transcription initiation start site. 
Cloning and analysis of the proximal regulatory region of Ttc39c-AT1 was conducted by transfecting C2C12 
myoblasts with either an empty reporter plasmid or a reporter plasmid containing (B) ~500 bp, (C) ~1000 bp or (D) 
~2000 bp of the Ttc39c-AT1 promoter fused to the Secreted Alkaline Phosphatase (SEAP) reporter gene. Each 
condition was performed in triplicate and each experiment was repeated at least once. The graphs are of a 
representative experiment and values correspond to the mean relative light unit (RLU) values ± SD. Significant 
difference between the control empty reporter plasmid (pSEAP2-Basic) and either the pSEAP-Ttc39c-Pro500-AT1, 










Figure 12. Schematic, sequence alignment, and analysis of the Ttc39c-AT2 alternative transcript promoter region. 





site (+1) through the first exon) were downloaded from the Ensembl database (www.ensembl.org) and aligned using 
the ClustalW algorithm. Approximate positions of putative transcription factor binding sites are indicated in the 
schematic of the (A) Ttc39c-AT2 regulatory region at the top. Putative TFIIB Response Element (BRE) 5’-
(G/C)(G/C(G/A)CGCC-3’ (shaded trapezoid), predicted Elk-1 binding element, 5’-CC(A/T)6GG-3’ (gray circle), 
predicted Runx1 binding element 5’-TGTGGT-3’ (stripped square), and putative consensus E-box elements 5’-
CANNTG-3’ (dotted triangle) are indicated. N represents any nucleotide. Conserved nucleotides are highlighted in 
black, transitions are highlighted in gray and transversions are highlighted in white. The black arrow indicates the 
position of the transcription initiation start site. Cloning and analysis of the proximal regulatory region of Ttc39c-AT2 
was conducted by transfecting C2C12 myoblasts with either an empty reporter plasmid or a reporter plasmid (B) ~500 
bp, (C) ~1000 bp or (D) ~2000 bp of the Ttc39c-AT2 promoter fused to the Secreted Alkaline Phosphatase (SEAP) 
reporter gene. Each condition was performed in triplicate and each experiment was repeated at least once. The graphs 
are of a representative experiment and values correspond to the mean relative light unit (RLU) values ± SD. Significant 
difference between the control empty reporter plasmid (pSEAP2-Basic) and either the pSEAP-Ttc39c-Pro500-AT2, 
pSEAP-Ttc39c-Pro1000-AT2, or pSEAP-Ttc39c-Pro2000-AT2 reporter constructs (****: P < 0.001). 
 
 
Ttc39c reporter gene activity is repressed in response to ectopic MRF expression 
Myogenic regulatory factors (MRF’s) are transcription factors important in muscle tissue 
formation and are known to regulate gene activity by interacting with co-activators or co-
repressors at the promoters of muscle-specific genes (Singh and Dilworth, 2013; Londhe and 
Davie, 2011). MRFs are characterized by having a basic helix-loop-helix (bHLH) motif, which 
promotes binding to a canonical E-box consensus sequence of 5’-CANNTG-3’ (where N can be 
any nucleotide base) (Singh and Dilworth, 2013; Londhe and Davie, 2011). These E-box 
sequences are found in the promoter regions of most muscle specific genes, and MRFs can bind 
directly to these E-boxes to modulate the transcriptional activity of genes that possess these 
enhancers (Londhe and Davie, 2011).  
 
Two MRFs important in skeletal muscle are MyoD and myogenin. MyoD acts as a marker of 
myogenic commitment to skeletal muscle and helps to maintain the differentiated state of muscle 
cells (Londhe and Davie, 2011). In addition, MyoD is important in the expression of myogenin in 
muscle cells, while myogenin also has a significant role in muscle cell differentiation and, unlike 
other MRFs, is required for cell viability (Londhe and Davie, 2011). Furthermore, it has been 
shown that the deletion of myogenin results in lower levels of MuRF1 in skeletal muscle and 
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resistance to muscle wasting in mice experiencing denervation-induced atrophy (Moresi, et al., 
2010).  
 
Neurogenic atrophy results in a dramatic increase in MRF expression, including significant 
increases in MyoD and myogenin expression (Merlie et al., 1994; Cohen et al., 2007; Tang et al., 
2009; Williams et al., 2009; Moresi et al., 2010; Furlow et al., 2013). Furthermore, the conserved 
E-box sequence identified in the two alternative Ttc39c regulatory regions matches the canonical 
E-box sequence (Fig. 11A and 12A, boxed sequences), which is the preferred sequence for MRF 
binding (Cao et al., 2010). Therefore, since MyoD1 and myogenin are elevated during neurogenic 
atrophy and are capable of binding canonical E-box elements in muscle-specific genes, we 
evaluated the ability of the Ttc39c reporters to respond to ectopic expression of MyoD1 and 
myogenin in C2C12 cells transiently transfected with the Ttc39c-AT1-Pro500 (Fig, 13A and 13B) 
and Ttc39c-AT2-Pro500 (Fig. 13C and 13D) wild-type reporter constructs. Interestingly, cells 
transiently transfected with MyoD1 (Fig. 13A and 13C) or myogenin (Fig. 13B and 13D) 
expression plasmids showed significantly lower Ttc39c reporter gene activity compared to cells 










Figure 13. Myogenic regulatory factors repress Ttc39c reporter gene activity. C2C12 myoblasts were transfected with 
the (A and B) pSEAP-Ttc39c-Pro500-AT1 or (C and D) pSEAP-Ttc39c-Pro500-AT2 reporter plasmids alone or in 
combination with (A and C) MyoD or (B and D) myogenin expression plasmids, a β-galactosidase reporter plasmid 
and filler DNA to 1µg/well of total DNA. The media was then assayed for SEAP activity at 72 hours following the 
switch to differentiation media and SEAP numbers were normalized to β-galactosidase activity to correct for variations 
in transfection efficiency. Each condition was performed in triplicate and each experiment was repeated at least once. 
The graphs are of a representative experiment and values correspond to the mean relative light unit (RLU) values ± 
SD. Significant differences between the activities of the pSEAP-Ttc39c-Pro500-AT1 and pSEAP-Ttc39c-Pro500-AT2 
reporter constructs alone compared to reporter gene activity in response to MyoD or myogenin overexpression are 





Characterization of conserved E-box elements in the regulatory regions of Ttc39c-AT1 and 
Ttc39c-AT2. 
A sequence matching the canonical E-box element sequence (5’-CANNTG-3’) was identified in 
the proximal promoter region of both Ttc39c alternative transcripts and found to be conserved in 
rodents and humans (Fig. 14A and 15A). Furthermore, additional consensus E-box elements were 
also identified in the proximal 2000 base pair regulatory regions of the two Ttc39c alternative 
transcripts (Fig. 14B and 15B). To determine if the conserved putative E-box elements are 
necessary for proper Ttc39c promoter activity, a site-directed mutagenesis strategy was developed 
and performed using the 500 base pair promoter fragments of the alternative Ttc39c reporter 
plasmids, resulting in the generation of the pSEAP-Ttc39c-Pro500-E-Box1, E-Box-2 and E-Box-
2 mutants for AT1 (Fig. 14C) and the pSEAP-Ttc9c-Pro500 E-box mutant for AT2 (Fig. 15C). 
Mutation of the conserved E-box in the Ttc39c-Pro500-AT1 promoter construct resulted in 
significantly lower reporter gene activity compared to the wild-type reporter construct, while 
constructs containing mutations of the non-conserved E-box elements had no significant effect on 
reporter gene activity in transiently transfected C2C12 cells (Fig. 14D). Additionally, mutation of 
the conserved E-box in the Ttc39c-Pro500-AT2 promoter construct also resulted in significantly 
lower reporter gene activity compared to the wild-type reporter construct in transiently transfected 
















Figure 14. Conserved E-boxes in the proximal regulatory region of Ttc39c-AT1 necessary for full reporter gene 
activity. Schematic, sequence alignment and analysis of the (A) Ttc39c-AT1 promoter region containing multiple 
putative consensus E-box elements 5’-CANNTG-3’ (dotted triangles). The starred triangle represents the conserved 
E-Box elements in the Ttc39c-AT1 regulatory region schematic and the sequences are boxed in the alignment. N 
represents any nucleotide. The Ttc39c-AT1 sequence alignment includes the proximal promoter region that contains 
three of the five putative E-boxes, the boxed sequence identifies the E-box conserved from human to rodents, and 
the underlined sequences identify the E-boxes conserved in rodents only. The sequences and locations of the 
putative consensus E-box elements in the (B) Ttc39c-AT1 regulatory region. Schematics of the site-directed 
mutagenesis strategy and corresponding nucleotide changes made to the proximal E-box elements in the (C) Ttc39c-
Pro500-AT1 reporter plasmid. (D) C2C12 myoblasts were transfected with the pSEAP-Ttc39c-Pro500-AT1 wild-
type, pSEAP-Ttc39c-Pro500-AT1-Ebox-1, pSEAP-Ttc39c-Pro500-AT1-Ebox-2, or pSEAP-Ttc39c-Pro500-AT1-




was then assayed for SEAP activity at 72 hours following the switch to differentiation media and SEAP numbers 
were normalized to β-galactosidase activity to correct for variations in transfection efficiency. All conditions were 
performed in triplicate and each experiment was repeated at least once. The graphs are of a representative 
experiment and values correspond to the mean relative light unit (RLU) values ± SD. Significant differences 
between the activities of the pSEAP-Ttc39c-Pro500 wild-type reporter constructs and the pSEAP-Ttc39c-Pro500 E-













Figure 15. Conserved E-boxes in the proximal regulatory region of Ttc39c-AT2 are necessary for full reporter gene 
activity. Schematic, sequence alignment and analysis of the (A) Ttc39c-AT2 promoter region containing multiple 
putative consensus E-box elements 5’-CANNTG-3’ (dotted triangles). The starred triangle represents the conserved 
E-Box element in the Ttc39c-AT2 regulatory region schematic and the sequence is boxed in the alignment. N 
represents any nucleotide. The sequences and locations of the putative consensus E-box elements in the (B) Ttc39c-
AT2 regulatory region. Schematic of the site-directed mutagenesis strategy and corresponding nucleotide changes 
made to the proximal E-box element in the (C) Ttc39c-Pro500-AT2 reporter plasmid. (D) C2C12 myoblasts were 
transfected with the pSEAP-Ttc39c-Pro500-AT2 wild-type or pSEAP-Ttc39c-Pro500-AT2-Ebox mutant reporter 
plasmids, a β-galactosidase reporter plasmid and filler DNA to 1µg/well of total DNA. The media was then assayed 
for SEAP activity at 72 hours following the switch to differentiation media and SEAP numbers were normalized to 
β-galactosidase activity to correct for variations in transfection efficiency. All conditions were performed in 
triplicate and each experiment was repeated at least once. The graphs are of a representative experiment and values 
correspond to the mean relative light unit (RLU) values ± SD. Significant differences between the activities of the 
pSEAP-Ttc39c-Pro500 wild-type reporter constructs and the pSEAP-Ttc39c-Pro500 E-box mutant reporter 
constructs, (**: P < 0.001). 
 
 
Ttc39c is regulated post-transcriptionally during muscle differentiation.  
Ttc39c expression reaches peak levels between late proliferation and early differentiation of 
muscle cells (Fig. 7C and 9). To determine if Ttc39c is being regulated at the post-transcriptional 
level, a 228 base pair fragment of the 3’ untranslated region (UTR) was cloned and fused to the 
3’end of the SEAP reporter gene to create the pSEAP-Report-Ttc39c-3’UTR reporter plasmid. The 




miRNA families and one conserved mammalian miRNA family (Fig. 16A). To determine if the 
Ttc39c 3’UTR has any regulatory capability, C2C12 myoblast cells were transfected with the 
pSEAP-Report-Ttc39c-3’UTR reporter plasmid and culture media was then analyzed for SEAP 
activity 24 hours post-transfection. Cells were then switched to differentiation media (2% serum) 
and culture media was further assayed at 24, 72, and 120 hours post-switch. Cells transfected with 
the pSEAP-Report-Ttc39c-3’UTR reporter plasmid showed decreasing SEAP activity as the cells 
differentiated compared to cells transfected with the pSEAP-Report control plasmid (Fig. 16B). 
These results suggest that the 3’UTR of Ttc39c may function in the post-transcriptional regulation 
of Ttc39c expression and is likely regulated by a poorly conserved mammalian miRNA or an 
unknown muscle-specific miRNA that is upregulated during muscle cell differentiation. The 
conserved miR-1193 microRNA is not likely to regulate Ttc39c expression, since the 3’UTR 








Figure 16. Ttc39c 3’untranslated region (3’-UTR) negatively regulates SEAP reporter gene activity during muscle 
cell differentiation. (A) Schematic of the mouse Ttc39c 3’-UTR showing the location of conserved mammalian 
miRNA seed sequences and broadly conserved vertebrate miRNA seed sequences. (B) 228 base pairs of the 3’-UTR 
of the mouse Ttc39c gene was cloned and fused with the 3’-end of the SEAP gene in the pSEAP-Report plasmid. 
C2C12 cells were transfected with either the pSEAP-Report plasmid or the pSEAP-Report-Ttc39c-3’-UTR plasmid 
and culture media was then assayed after day 2 (PD2) in proliferation media prior to switching the cells to 
differentiation media (2% serum) and analyzing at day 1 (DD1), day 3 (DD3) and day 5 (DD5) post-media switch. 
Cells transfected with the pSEAP-Report-Ttc39c-3’-UTR plasmid showed significantly lower SEAP activity as the 
cells differentiated compared to cells transfected with the pSEAP-Report control plasmid. Significant differences 
between the activities of the pSEAP-Report empty control plasmid and the pSEAP-Report-Ttc39c-3’-UTR plasmid, 
(****: P < 0.001). The schematic image of the murine Ttc39c 3’-UTR was downloaded from the TargetScan database 
Release 7.1 (www.targetscan.org). 
 
 
Sub-cellular localization of Ttc39c.  
This study is one of the first to describe Ttc39c in muscle and as a consequence very little has been 
reported for this protein. Therefore, in order to further characterize Ttc39c in muscle cells, sub-
cellular localization was analyzed by fusing the Ttc39c cDNA in frame with the GFP cDNA. C2C12 
cells were then transfected with either the pEGFP control plasmid or the pEGFP-Ttc39c expression 
plasmid and cells were subsequently imaged by confocal fluorescent microscopy. C2C12 cells 
transfected with the pEGFP control vector showed uniform intracellular distribution of GFP in 
B. 
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both proliferating myoblasts (Fig. 17, panels A-C and J-L) and differentiating myotubes (Fig. 18, 
panels A-C and J-L). In contrast, C2C12 cells transfected with the pEGFP-Ttc39c expression 
plasmid resulted in strong cytoplasmic localization and nuclear exclusion in both proliferating 
myoblasts (Fig. 17, panels D-I and M-R) and in differentiating myotubes (Fig. 18, panels D-I and 
M-R). Interestingly, C2C12 cells transfected with GFP-Ttc39c appear to show fluorescence at the 
centrosome and association with microtubules radiating out from the centrosome (Fig. 18, panels 
M-O, white arrows). Furthermore, cells overexpressing GFP-Ttc39c developed elongated 
protrusions (Fig. 18, panels D-I and M-R, red arrows) that were not observed in cells transfected 





Figure 17. Ttc39c localizes to the cytoplasm in C2C12 myoblast cells. Proliferating C2C12 cells transfected with the 
empty pEGFP-C1 expression vector were imaged at 20X (A-C) and 60X (J-L) magnification and uniform cellular 
localization of GFP was observed. Representative C2C12 cells transfected with a pEGFP-Ttc39c expression plasmid 





Figure 18. Ttc39c overexpression alters primary cilia structure in differentiating C2C12 muscle cells. Differentiating 
C2C12 cells transfected with the empty pEGFP-C1 expression vector were imaged at 20X (A-C) and 60X (J-L) 
magnification and displayed uniform cellular localization of GFP and normal myofiber formation. Representative 
C2C12 cells transfected with a pEGFP-Ttc39c expression plasmid were imaged at 20X (D-I) and 60X (M-R) 
magnification and displayed cytoplasmic fluorescence, elongated primary cilia (red arrows) and association with the 
centrosome and microtubules (white arrows). 
 
Ectopic expression of Ttc39c inhibits muscle cell differentiation.  
The pcDNA3-Ttc39c expression plasmid was transfected into C2C12 mouse myoblasts and cells 
were then harvested at 24 hours post-transfection (PD2), while the remaining cells were switched 
to differentiation media (2% serum) and harvested at 24, 48, 72, and 96 hours post-media switch. 
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Western blots were then performed to analyze markers of muscle cell differentiation over the time 
course. Mouse monoclonal antibodies against Myosin Heavy Chain (MyHC), myogenin (1:500 
dilution) and MyoD (1:500 dilution) were used to analyze the expression of these canonical 
markers of muscle cell differentiation in control muscle cells and cells ectopically expressing 
Ttc39c. Overexpression of Ttc39c resulted in decreased expression of MyHC, myogenin and 
MyoD in early differentiation (DD1 and DD2), but did not prevent muscle cells from eventually 
differentiating (DD3 and DD4) (Fig. 19). Interestingly, Ttc39c overexpression, analyzed using a 
mouse monoclonal antibody against Ttc39c (1:1000 dilution), decreased dramatically as cells 
differentiated, which correlates with the increased expression of muscle cell differentiation 
markers (Fig. 19) and suggests that Ttc39c is likely post-translationally regulated during muscle 
cell differentiation. Acetylated tubulin, an additional marker of muscle cell differentiation, was 
also analyzed using a mouse monoclonal antibody (1:1000 dilution) that recognizes acetylation of 
the lysine 40 residue of α-tubulin and was found to show decreased levels of acetylation throughout 
differentiation (Fig 19). α-tubulin protein levels were analyzed to confirm equal protein loading 
and demonstrated that α-tubulin subunit levels remained constant from proliferation through 
differentiation (Fig. 19).      
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Figure 19.  Ectopic expression of Ttc39c in C2C12 muscle cells represses muscle cell differentiation. Proliferating 
(PD) and differentiated (DD) control C2C12 cells and cells overexpressing Ttc39c were harvested over a 4 day 
differentiation time course and protein lysates were then analyzed by Western blot. Cells were maintained in 
proliferation media (10% serum) and harvested 2 days post-plating and the remaining cells were then switched to 
differentiation media (2% serum) and harvested at 1, 2, 3 and 4 days post-media change. Cells transfected with the 
Ttc39c expression plasmid showed dramatically higher levels of Ttc39c expression compared to control cells when 
blots were probed using an antibody against Ttc39c. Myosin Heavy Chain (MyHC) was analyzed as a marker of 
muscle cell differentiation and found to be inhibited in cells overexpression Ttc39c. Myogenic regulatory factors, 
myogenin and MyoD, were also found to have lower expression in muscle cells overexpressing Ttc39c during early 
differentiation, while acetylated tubulin, another marker of muscle differentiation, also displayed lower levels in cells 
overexpressing Ttc39c. α-tubulin was analyzed to confirm equal protein loading. The experiments were repeated at 
least once and the western blots are representative examples of the results obtained.  
 
 
To confirm that muscle cells overexpressing Ttc39c had lower levels of MyoD and myogenin 
available to regulate muscle-specific gene expression, a reporter gene construct was created by 
fusing 4 canonical E-box elements with a minimal SV40 promoter to create the pSEAP-Pro-Ebox-
4X reporter plasmid. The E-box reporter was transfected into C2C12 cells with or without Ttc39c 
ectopic expression and reporter gene activity was measured over a 7 day differentiation time course 
by sampling the growth media every 48 hours and analyzing the level of secreted alkaline 
phosphatase (SEAP) activity. Muscle cells overexpressing Ttc39c showed significantly lower 
MRF reporter gene activity compared to control cells over the entire 7 day time course (Fig. 20).  
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Figure 20. Ectopic overexpression of Ttc39c in C2C12 muscle cells represses myogenic regulatory factor activity. 
Myogenic regulatory factor activity was analyzed using a reporter gene that consisted of a minimal SV40 promoter 
fused with 4 concatemerized E-box consensus elements. C2C12 cells were transfected with either the reporter alone 
(black line) or in combination with the pcDNA3-Ttc39c expression plasmid (gray line) and culture media was 
analyzed over a 7 day time course post-media switch. Cells ectopically expression Ttc39c showed a significantly 
lower levels of myogenic regulatory factor activation of the E-box reporter construct compared to control cells. 
Significant differences between reporter gene activity in control cells compared to cells ectopically expressing Ttc39c, 
(*: P < 0.001). 
 
Ectopic expression of Ttc39c attenuates MAP Kinase and Hedgehog signaling pathways in muscle 
cells. 
Ttc39c was overexpressed in C2C12 myoblasts and cells were then harvested at 24 hours post-
transfection (PD2), while the remaining cells were switched to differentiation media (2% serum) 
and harvested at 24, 48, 72, 96 and 120 hours post-media switch. Western blots were then 
performed to evaluate markers of MAP Kinase signaling pathway activity over the time course. A 
mouse monoclonal antibody against phosphorylated ERK (p-ERK) that recognizes an epitope that 
includes phosphorylated Tyrosine 204 (1:500 dilution) was used to analyze the level of p-ERK in 
muscle cells ectopically expressing Ttc39c compared to control cells. Overexpression of Ttc39c 
resulted in significantly lower levels of p-ERK in cells overexpressing Ttc39c (Fig. 21A). 
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Interestingly, when overall ERK protein levels were assessed using a rabbit polyclonal antibody 
(1:500), cells overexpressing Ttc39c actually showed elevated ERK expression compared to 
control cells at later stages of differentiation (DD3-DD5) (Fig. 21A).  
 
In addition to the MAP kinase signaling pathway, Western blots were also performed to evaluate 
the activity of the Hedgehog (Hh) signaling pathway over the time course. A rabbit polyclonal 
antibody against Gli2 (1:1000 dilution) was used to analyze the level of Gli2 repressor and a 
proteolytic cleavage product of Gli2 in muscle cells ectopically expressing Ttc39c compared to 
control cells. Overexpression of Ttc39c resulted in significantly higher levels of repressor Gli2 in 
cells overexpressing Ttc39c during differentiation (DD2-DD4) (Fig. 21B). Interestingly, a 
proteolytic cleavage product of Gli2 was detected in muscle cells and this product also showed 
elevated levels in cells overexpressing Ttc39c during differentiation (DD2-DD4) (Fig. 21B). As 
expected, Ttc39c expression was higher in cells transfected with the Ttc39c expression plasmid, 
but decreased dramatically as muscle cells differentiated, while α-tubulin protein levels remained 










Figure 21. Ectopic expression of Ttc39c in C2C12 muscle cells attenuates MAP Kinase and Hedgehog Signaling 
Pathways. Proliferating (PD) and differentiated (DD) control C2C12 cells and cells overexpressing Ttc39c were 
harvested over a 4 day differentiation time course and protein lysates were then analyzed by Western blot. Cells were 
maintained in proliferation media (10% serum) and harvested 2 days post-plating and the remaining cells were then 
switched to differentiation media (2% serum) and harvested at 1, 2, 3, and 4 (Hedgehog Signaling) or 1, 2, 3, 4 and 5 
days (MAP Kinase Signaling) post-media change. Cells transfected with the Ttc39c expression plasmid showed 
significantly higher levels of Ttc39c expression compared to control cells. (A) Phosphorylated Erk was significantly 
lower in Ttc39c overexpressing cells during muscle cell differentiation, while the levels of the Erk protein were 
elevated in cells ectopically expressing Ttc39c. (B) The Gli2 repressor isoform is elevated in C2C12 cells 
overexpressing Ttc39c in later differentiation. α-tubulin was analyzed to confirm equal protein loading. These 
experiments were repeated at least once and the Western blots are representative examples of the results obtained.  
 
To confirm that muscle cells overexpressing Ttc39c had decreased MAP kinase signaling, a 
reporter gene construct was created by fusing a canonical AP-1 element with a minimal SV40 
promoter to create the pSEAP-Pro-AP-1 reporter plasmid. The AP-1 reporter was transfected into 
C2C12 cells with or without Ttc39c ectopic expression and reporter gene activity was measured 
over a 7 days differentiation time course by sampling the growth media every 48 hours and 
analyzing the level of secreted alkaline phosphatase (SEAP) activity (Fig. 22A). Muscle cells 
overexpressing Ttc39c showed significantly lower AP-1 reporter gene activity compared to control 
cells over the entire 7 day time course (Fig. 22B). In addition, Hh signaling was also assessed in 
B. 
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muscle cells overexpressing Ttc39c revealing decreased signaling activity. To monitor Hh 
signaling, a reporter gene construct was created by fusing a Gli consensus binding element with a 
minimal SV40 promoter to create the pSEAP-Pro-Gli reporter plasmid. The Gli reporter was 
transfected into C2C12 cells with or without Ttc39c ectopic expression and reporter gene activity 
was measured over a 7 days differentiation time course by sampling the growth media every 48 
hours and analyzing the level of secreted alkaline phosphatase (SEAP) activity (Fig 22A). Muscle 
cells overexpressing Ttc39c showed significantly lower Gli reporter gene activity compared to 








Figure 22. Ectopic expression of Ttc39c in C2C12 muscle cells represses AP-1 and Gli reporter activity. (A) Schematic 
of the signaling pathway reporter gene experimental design. C2C12 cells were transfected one day post-plating and 
maintained in proliferation media for an additional 24 hours post-transfection. The cells were then changed to 
differentiation media (2% serum) and analyzed for reporter gene actively at 1, 3, 5, and 7 days post-media switch. (B) 
The MAP Kinase signaling pathway was analyzed using a reporter gene that consisted of a minimal SV40 promoter 
fused with an AP-1 consensus element. C2C12 cells were transfected with either the reporter alone (black line) or in 
combination with the pcDNA3-Ttc39c expression plasmid (gray line) and culture media was analyzed over a 7 day 
time course post-media switch. Cells ectopically expression Ttc39c showed a significantly lower level of MAP Kinase 
signaling compared to control cells. (C) The Hedgehog signaling pathway was analyzed using a reporter gene that 
consisted of a minimal SV40 promoter fused with a Gli consensus element. C2C12 cells were transfected with either 
the reporter alone (black line) or in combination with the pcDNA3-Ttc39c expression plasmid (gray line) and culture 
media was analyzed over a 7 day time course post-media switch. Cells ectopically expressing Ttc39c showed a 
significantly lower level of Hedgehog signaling compared to control cells. Significant differences between reporter 
gene activity in control cells compared to cells ectopically expressing Ttc39c, (*: P < 0.001). 
 
Ttc39c overexpression results in increased IFT144 protein levels in muscle cells. 
Ttc39c was overexpressed in C2C12 mouse myoblasts and cells were then harvested at 24 hours 
post-transfection (PD2), while the remaining cells were switched to differentiation media (2% 
serum) and harvested at 24, 48, 72, 96 and 120 hours post-media switch. Western blots were 
performed to analyze the expression level of IFT88, a component of the anterograde intraflagellar 
transport (IFT) complex B, and IFT144, a component of the retrograde intraflagellar transport 
complex A in muscle cells. Since previous research has shown that Ttc39c interacts with IFT144, 
a rabbit polyclonal antibody against IFT144 (1:1000 dilution) was used to analyze the expression 
C. 
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level of IFT144 in response to Ttc39c ectopic expression. Overexpression of Ttc39c resulted in an 
increase in expression of IFT144 as cells differentiated (DD3-DD5) (Fig. 23). Interestingly, Ttc39c 
overexpression did not significantly impact IFT88 protein levels in proliferating or differentiated 
muscle cells (Fig. 23). Ttc39c expression was again found to decrease dramatically as muscle cells 
differentiated, while α-tubulin protein levels remained constant from proliferation through 
differentiation (Fig. 23). 
 
Figure 23. Ectopic expression of Ttc39c in C2C12 muscle cells increases IFT144 protein levels. C2C12 cells were 
transfected with the pcDNA3-Ttc39c expression plasmid and western blot analysis was performed using an antibody 
against Ttc39c on protein homogenates from differentiated (DD) C2C12 cells harvested over a 5 day differentiation 
time course. Cells were maintained in proliferation media (10% serum) 2 days post-plating and then switched to 
differentiation media (2% serum) and harvested at 1, 2, 3, 4 and 5 days post-media change. Cells transfected with the 
pcDNA3-Ttc39c expression plasmid showed significantly higher levels of Ttc39c expression compared to control 
cells. IFT144 is part of the Intraflagellar Transport system and is a component of Complex A, which participates in 
retrograde transport in the primary cilia. Ttc39c overexpression results in elevated IFT144 protein levels in 
differentiating muscle cells. Conversely, IFT88 is also part of the Intraflagellar Transport system and is a component 
of Complex B, which participates in anterograde transport in the primary cilia. Ttc39c overexpression did not impact 
IFT88 protein levels in proliferating or differentiating muscle cells. α-tubulin was analyzed to confirm equal protein 
loading. These experiments were repeated at least once and the western blots are representative examples of the results 
obtained. 
 
siRNA knockdown of Ttc39c alters myoblast cell morphology. 
The cDNA of Ttc39c was cloned from mouse muscle cells, sequenced in both directions and found 
to contain no mutations or unknown polymorphisms based on comparisons to the sequence on 
deposit in the Ensembl database (Ttc39c) (Fig 24A). This Ttc39c cDNA sequence was then 
analyzed for potential siRNA targeting sequences and two target sites (highlighted in red) were 
identified and used to create siRNA oligonucleotides that were subsequently cloned into the 
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pSuper-Basic expression plasmid. C2C12 cells were transfected with the pSuper-Basic plasmid or 
the pSuper-Ttc39c-siRNA-2 or the pSuper-Ttc39c-siRNA-3 plasmids and cells were harvested 48 
hours post-transfection. Protein lysates purified from transfected cells were then analyzed by 
Western blot to determine the efficiency of siRNA knockdown of Ttc39c and the targeting 
sequences were found to dramatically reduce Ttc39c levels in cells transfected with the Ttc3c-
siRNA expression plasmids compared to control cells and cells transfected with the pSuper-Basic 
control plasmid (Fig. 24B). Interestingly, C2C12 cells transfected with the Ttc39c-siRNA-3 plasmid 
also demonstrated dramatic morphological changes (Fig. 24D and 24F), compared to control cells 





































Figure 24. Knockdown of Ttc39c expression in C2C12 muscle cells results in changes in muscle cell morphology. (A) 
Sequence of the cDNA of Ttc39c cloned from mouse muscle cells and the location of the siRNA targeting sequences 
(highlighted in red). (B) C2C12 cells were transfected with either the pSuper empty plasmid or pSuper plasmids that 
contained oligonucleotide sequences for targeting the Ttc39c mRNA transcript for transient knockdown (pSuper-
Ttc39c-siRNA-2 and pSuper-Ttc39c-siRNA-3). Phase microscopic analysis of C2C12 cells transfected with either the 
pSuper-empty plasmid at (C) 4X and (E) 10X or the pSuper-Ttc39c-3 siRNA expression plasmid at (D) 4X and (F) 
10X. 
 
Ttc39 knockdown inhibits muscle cell differentiation. 
The sSuper-Ttc39c-siRNA-3 expression plasmid was transfected into C2C12 mouse myoblasts and 
cells were switched to differentiation media (2% serum) and harvested at 24, 48, 72 and 96 hours 
post-media switch. Western blots were then performed to evaluate the expression levels of markers 
of muscle cell differentiation over the time course. Knockdown of Ttc39c resulted in significant 
reduction of MyHC and myogenin throughout differentiation (DD1-DD4) (Fig. 25). Effective 
siRNA knockdown of Ttc39c expression was confirmed, while α-tubulin protein levels remained 




Figure 25.  Loss of Ttc39c expression in C2C12 muscle cells represses muscle cell differentiation. C2C12 cells were 
transfected with the pSuper-siRNA control plasmid or the pSuper-Ttc39c-3 siRNA expression plasmid and Western 
blot analysis was performed on protein homogenates from differentiated (DD) C2C12 cells harvested over a 4 day 
differentiation time course. Cells were maintained in proliferation media (10% serum) 2 days post-plating and then 
switched to differentiation media (2% serum) and harvested at 1, 2, 3, and 4 days post-media change. Cells transfected 
with the pSuper-Ttc39c-3 siRNA expression plasmid showed significantly lower levels of Ttc39c expression 
compared to control cells (top panel). Myosin Heavy Chain (MyHC) was analyzed as a marker of muscle cell 
differentiation and found to be significantly lower in cells with reduced Ttc39c expression (second panel from top). 
The myogenic regulatory factor, myogenin, also showed lower expression in Ttc39c knockdown cells (third panel 
from the top). α-tubulin was analyzed to confirm equal protein loading (bottom panel). The experiments were repeated 
at least once and the western blots presented are representative examples.  
 
To assess the impact that Ttc39c knockdown has on muscle differentiation, the pSEAP-Pro-Ebox-
4X reporter plasmid was transfected into C2C12 cells with or without Ttc39c repression and 
reporter gene activity was measured over a 5 day differentiation time course by sampling the 
growth media every 48 hours and analyzing the level of secreted alkaline phosphatase (SEAP) 
activity. Muscle cells with repressed Ttc39c expression showed significantly lower MRF reporter 
gene activity compared to control cells over the entire 5 day time course (Fig. 26). 
 62 
 
Figure 26. Loss of Ttc39c in C2C12 muscle cells represses myogenic regulatory factor activity. Myogenic regulatory 
factor activity was analyzed using a reporter gene that consisted of a minimal SV40 promoter fused with 4 
concatemerized E-box consensus elements. C2C12 cells were transfected with either the reporter alone (black line) or 
in combination with the pSuper-Ttc39c-3 siRNA expression plasmid (gray line) and culture media was analyzed over 
a 5 day time course post-media switch. Cells with decreased Ttc39c protein levels showed significantly lower levels 
of myogenic regulatory factor activation of the E-box reporter construct compared to control cells. Significant 
differences between reporter gene activity in control cells compared to Ttc39c knockdown cells, (*: P < 0.001). 
 
 
Knockdown of Ttc39c expression attenuates MAP Kinase and Hedgehog signaling pathways in 
muscle cells. 
Ttc39c was transiently knocked down in C2C12 myoblasts and cells were then switched to 
differentiation media (2% serum) and harvested at 24, 48, 72, and 96 hours post-media switch. 
Western blots were then performed to analyze markers of MAP Kinase signaling pathway activity 
over the time course. Knockdown of Ttc39c resulted in significantly lower levels of p-ERK in cells 
with lower levels of Ttc39c, while overall ERK protein levels remained unchanged in Ttc39c 
knockdown cells (Fig. 27). In addition to the MAP kinase signaling pathway, Western blots were 
also performed to evaluate the activity of the Hedgehog (Hh) signaling pathway over the time 
course. Ttc39c repression resulted in lower levels of the repressor Gli2 and the Gli2 proteolytic 
 63 
cleavage product in Ttc39c knockdown cells during early differentiation (DD2) (Fig. 27). As 
expected, Ttc39c knockdown was effectively achieved in cells transfected with the pSuper-Ttc39c-
siRNA-3 expression plasmid, while α-tubulin protein levels remained relatively constant from 
proliferation through differentiation (Fig. 27).  
 
Figure 27.  Loss of Ttc39c in C2C12 muscle cells attenuates MAP Kinase and Hedgehog Signaling Pathways in muscle 
cells. C2C12 cells were transfected with the pSuper-siRNA control plasmid or the pSuper-Ttc39c-3 siRNA expression 
plasmid and Western blot analysis was performed on protein homogenates from differentiated (DD) C2C12 cells 
harvested over a 4 day differentiation time course. Cells were maintained in proliferation media (10% serum) 2 days 
post-plating and then switched to differentiation media (2% serum) and harvested at 1, 2, 3, and 4 days post-media 
change. (A) Cells transfected with the Ttc39c siRNA expression plasmid showed significantly lower levels of Ttc39c 
expression compared to control cells (top panel). Levels of phosphorylated Erk (panel second from top) were 
significantly lower in Ttc39c knockdown cells during muscle cell differentiation, while the levels of the Erk protein 
(panel third from top) remained constant in control cells and Ttc39c knockdown cells. The Gli2 repressor isoform is 
higher in C2C12 control cells in early differentiation compared to Ttc39c knockdown cells (panel fourth from top). α-
tubulin was analyzed to confirm equal protein loading (bottom panel). These experiments were repeated at least once 
and the Western blots are representative examples of the results obtained.  
 
 
To determine the level of MAP kinase signaling in muscle cells with repressed Ttc39c expression, 
the pSEAP-Pro-AP-1 reporter plasmid was transfected into C2C12 cells with or without the Ttc39c-
siRNA-3 expression plasmid and reporter gene activity was measured over a 5 day differentiation 
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time course by sampling the growth media every 48 hours and analyzing the level of secreted 
alkaline phosphatase (SEAP) activity (Fig 28A). Muscle cells with Ttc39c knocked down showed 
significantly lower AP-1 reporter gene activity compared to control cells over the entire 5 day time 
course (Fig. 28B). In addition, Hh signaling was also assessed in muscle cells with repressed 
Ttc39c expression. To monitor Hh signaling pathway activity, the pSEAP-Pro-Gli reporter plasmid 
was transfected into C2C12 cells with or without the Ttc39c-siRNA-3 expression plasmid and 
reporter gene activity was measured over a 5 day differentiation time course by sampling the 
growth media every 48 hours and analyzing the level of secreted alkaline phosphatase (SEAP) 
activity (Fig 28A). Muscle cells with Ttc39c repression showed significantly lower Gli reporter 







Figure 28. Loss of Ttc39c in C2C12 muscle cells repressed AP-1 and Gli reporter activity. (A) Schematic of the 
signaling pathway reporter gene experimental design. C2C12 cells were transfected one day post-plating and 
maintained in proliferation media for an additional 24 hours post-transfection. The cells were then changed to 
differentiation media (2% serum) and analyzed for reporter gene actively at 1, 3, and 5 days post-media switch. (B) 
The MAP Kinase signaling pathway was analyzed using a reporter gene that consisted of a minimal SV40 promoter 
fused with an AP-1 consensus element. C2C12 cells were transfected with either the reporter alone (black line) or in 
combination with the pSuper-Ttc39c-3 siRNA expression plasmid (gray line) and culture media was analyzed over a 
5 day time course post-media switch. Cells with decreased Ttc39c protein levels showed significantly lower levels of 
MAP Kinase signaling compared to control cells. (C) The Hedgehog signaling pathway was analyzed using a reporter 
gene that consisted of a minimal SV40 promoter fused with a Gli consensus element. C2C12 cells were transfected 
with either the reporter alone (black line) or in combination with the pSuper-Ttc39c-3 siRNA expression plasmid 
(gray line) and culture media was analyzed over a 5 day time course post-media switch. Cells with lower Ttc39c 
expression showed significantly lower levels of Hedgehog signaling compared to control cells. Significant differences 
between reporter gene activity in control cells compared to Ttc39c knockdown cells, (*: P < 0.001). 
 
Ttc39c knockdown does not affect IFT88 or IFT144 protein levels in muscle cells. 
Ttc39c expression was transiently knocked down in C2C12 mouse myoblasts and cells were then 
switched to differentiation media (2% serum) and harvested at 24, 48, 72 and 96 hours post-media 
switch. Western blots were again performed to analyze the expression level of IFT88 and IFT144, 
in muscle cells with repressed Ttc39c expression. Knockdown of Ttc39c had no significant impact 
on IFT144 or IFT88 protein levels in muscle cells (Fig. 29). siRNA knockdown of Ttc39c was 
confirmed to be highly effective, while α-tubulin protein levels remained relatively constant from 




Figure 29.  Knockdown of Ttc39c in C2C12 muscle cells does not affect IFT88 or IFT144 protein levels. C2C12 cells 
were transfected with the pSuper-siRNA control plasmid or the pSuper-Ttc39c-3 siRNA expression plasmid and 
western blot analysis was performed using an antibody against Ttc39c on protein homogenates from differentiated 
(DD) C2C12 cells harvested over a 4 day differentiation time course. Cells were maintained in proliferation media 
(10% serum) 2 days post-plating and then switched to differentiation media (2% serum) and harvested at 1, 2, 3, and 
4 days post-media change. Cells transfected with the pSuper-Ttc39c-3 siRNA expression plasmid showed significantly 
lower levels of Ttc39c expression compared to control cells. IFT144 is part of the Intraflagellar Transport system and 
is a component of Complex A, which participates in retrograde transport in the primary cilia. IFT88 is part of the 
Intraflagellar Transport system and is a component of Complex B, which participates in anterograde transport in the 
primary cilia.Ttc39c knockdown had no effect on IFT144 or IFT88 protein levels in differentiating muscle cells. α-
tubulin was analyzed to confirm equal protein loading. These experiments were repeated at least once and the Western 
blots presented are representative examples. 
 
Discussion  
Ttc39c is upregulated in neurogenic skeletal muscle atrophy.  
When skeletal muscle tissue is damaged or lost due to atrophy, muscle stem cells, called satellite 
cells, are activated and divide in an attempt to compensate for the loss of muscle tissue (Bentzinger, 
et al., 2012; Dasarathy, et al., 2004). MuRF1 has long been believed to be a major regulator of 
skeletal muscle atrophy by functioning as an E3 ubiquitin ligase that targets proteins for 
degradation, while more recent data suggests that MuRF1 may also act as a transcriptional 
regulator of gene expression during atrophy conditions (Bodine, et al., 2001; Bodine and Baehr, 
2014; Furlow et al., 2013). Interestingly, microarray data presented in this study shows that Ttc39c 
expression is increased both 3 days and 14 days post-denervation in wild-type animals, but in 
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MuRF1-null mice, Ttc39c expression is not significantly induced at 3 days or 14 days post-
denervation (Fig. 6A and 6B). These data suggest that Ttc39c expression is reliant on MuRF1 
expression during neurogenic skeletal muscle atrophy conditions and that Ttc39c is involved in 
the atrophy pathway.  
 
Ttc39c is expressed at the mRNA and protein level in skeletal muscle.  
Since Ttc39c was observed being upregulated in neurogenic atrophy, this study wanted to validate 
its expression profile in differentiating skeletal muscle cells. Data presented in this study shows 
the expression profile for Ttc39c in vitro, as the qPCR data from C2C12 myoblasts show elevated 
mRNA expression at differentiation day 2 (DD2) compared to proliferation day 2 (PD2), but by 
differentiation day 7 (DD7) the mRNA expression levels returned to baseline (Fig. 7C). Western 
blot analysis confirmed these time points, as Ttc39c protein expression in C2C12 myoblasts is 
highest at PD2 through DD2, but then drops off dramatically by DD3 (Fig. 9). This study also 
confirmed through reporter gene analysis that the proximal promoter regions of both alternative 
transcripts of Ttc39c show activity in skeletal muscle cells, as these regions contain several 
conserved regulatory elements (Fig. 11B-D, 12B-D). This shows Ttc39c expression is induced via 
the promoter regions of each transcript and suggests that Ttc39c has a narrow window of function 
within early muscle cell differentiation. 
 
Ttc39c is regulated transcriptionally via muscle-specific transcription factors and post-
transcriptionally via its 3’UTR in vitro. 
As previously described, MRFs are muscle-specific transcription factors responsible for regulating 
gene expression during myogenesis and do so via binding canonical E-box consensus sequences 
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in the promoter regions of these genes (Singh and Dilworth, 2013; Londhe and Davie, 2011). 
MRFs can bind E-box sequences by forming homodimers or by forming heterodimers with 
ubiquitously expressed E-proteins such as TCF3 and TCF12 (Singh and Dilworth, 2013; Londhe 
and Davie, 2011). Both transcripts of Ttc39c contain conserved E-box sequences in their 500 bp 
proximal promoters, so reporter assays were conducted to test the effect of MRFs on these 
promoter fragments. MyoD and myogenin exhibited repression of reporter gene activity for both 
Ttc39c transcripts (Fig. 13A-D). For the Ttc39c-580 and the Ttc39c-522 transcripts, both MyoD 
and myogenin repressed promoter activity (Fig. 13A-D). Both transcripts also showed differential 
promoter activity compared to the WT promoter when these conserved E-box sequences were 
mutagenized to inhibit the binding of MRFs (Fig. 14D and 15D). This data suggests the expression 
of Ttc39c in skeletal muscle is regulated by MRFs, and it is the binding of MRFs to conserved E-
box sequences that facilitates this transcriptional regulation. 
In addition to containing conserved E-box sequences in its promoter region, Ttc39c also possesses 
a short 3’UTR region which is likely bound by miRNAs to post-transcriptionally regulate the 
expression of Ttc39c. To see if the 3’UTR had any possible regulatory effects on Ttc39c, this 
segment of the gene was cloned into a reporter plasmid and transfected into C2C12 myoblasts. The 
data shows that, as differentiation proceeds, the reporter activity of the Ttc39c 3’UTR construct 
decreases when compared to the control reporter construct (Fig. 16B). This suggests that the 
expression of Ttc39c is regulated at both the transcriptional and post-transcriptional level in 





The TPR domains of Ttc39c may facilitate protein-protein interactions. 
As the exact function of Ttc39c has yet to be elucidated, this study wanted to identify putative 
functional domains of Ttc39c. This study’s analysis of the functional domains of the 580 amino 
acid and 522 amino acid isoforms of Ttc39c reveals that both transcripts contain a DUF region that 
includes 4 putative TPR domains (Fig. 10). The presence of these TPR domains points to the 
potential function of Ttc39c as a scaffolding protein that could facilitate protein-protein 
interactions and help assemble protein complexes. Indeed, previous research has shown that TPR 
domains do facilitate protein-protein interactions and can act as scaffolds for larger protein 
complexes (Zeytuni and Zarivach, 2012). This potential function of Ttc39c as a scaffolding protein 
warranted further study into where Ttc39c is localizing and what it is possibly associating with in 
skeletal muscle cells. 
 
Ttc39c localizes to the cytoplasm and associates with the centrosome in skeletal muscle cells. 
This study is the first to describe Ttc39c in skeletal muscle, so confocal fluorescent microscopy 
was utilized to observe the subcellular localization of the Ttc93c protein. Ttc39c was fused in 
frame with GFP, transfected into C2C12 myoblasts, and visualized at proliferation and 
differentiation time points. The transfected Ttc39c-GFP cells showed localization to the cytoplasm 
and nuclear exclusion, while also showing possible association with the centrosome and the 
microtubules radiating from it (Fig. 17D-I, 17M-R, 18D-I, and 18M-R). Furthermore, the images 
show aberrant protrusions growing from differentiating cells transfected with the Ttc39c-GFP 
expression plasmid (Fig. 18D-I and 18M-R). This result could be due to aberrant microtubule 
growth, but the exact mechanism remains unclear. Further investigation is required to confirm the 
associations with the centrosome and elucidate what is causing the aberrant protrusions. 
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Regardless, the overexpression of Ttc39c results in aberrant morphology of skeletal muscle cells 
and a lack of proper skeletal muscle cell differentiation. 
 
Ectopic overexpression of Ttc39c inhibits myoblast differentiation 
Confocal fluorescent microscopy revealed that overexpressing Ttc39c results in aberrant skeletal 
muscle cell morphology during differentiation. To observe if Ttc39c has any effect on myogenesis, 
Ttc39c was ectopically expressed in C2C12 myoblasts over a time course ranging from proliferation 
to late differentiation. Protein lysates from these cells were then analyzed via Western blot, probing 
for MyHC, MyoD, and myogenin as markers of muscle cell differentiation. Compared to the 
control cells, the cells overexpressing Ttc39c showed a dramatic reduction in MyHC, MyoD, and 
myogenin (Fig. 19), suggesting that overexpression of Ttc39c inhibits myoblast differentiation in 
vitro.  
To confirm that overexpressing Ttc39c results in lower levels of MyoD and myogenin, an E-box 
reporter construct was transfected into C2C12 myoblasts with or without Ttc39c overexpression and 
the reporter activity was measured over a 7 day time course. As expected, the E-box reporter 
activity in the cells overexpressing Ttc39c was significantly lower than the control cells (Fig. 20), 
suggesting that reduction in MRF expression due to Ttc39c overexpression inhibited 
differentiation by reducing muscle-specific gene expression required for myogenesis in vitro.  
 
Ectopic overexpression of Ttc39c attenuates MAPK and Hh signaling in myoblasts. 
Several signaling pathways are required for proper myogenesis, including the ERK1/2 pathway of 
the MAPK signaling cascade and the Hh signaling pathway (Bentzinger, et al., 2012; Mok and 
Sweetman, 2011; Bismuth and Relaix, 2010; Fu, et al., 2014; Knight and Kothary, 2011). If the 
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signaling of these pathways is impaired, proper myogenesis cannot occur (Koleva, et al., 2005; Li, 
et al., 2004; Sarbassov, et al., 1997; Winter and Arnold, 2000). To observe any effects on these 
signaling pathways in the Ttc39c overexpression cells, Western blots were probed for ERK, p-
ERK, and Gli2 repressor. Activation of the ERK1/2 pathway leads to the phosphorylation and 
activation of ERK. Phosphorylated ERK (p-ERK) then acts downstream to control cell 
proliferation, migration, and cell differentiation (Christensen et al., 2012). Compared to control 
cells, p-ERK levels were significantly reduced in the Ttc39c overexpression samples, while overall 
ERK levels remained relatively constant (Fig. 21A). These findings suggest that overexpression 
of Ttc39c affects the activation of the MAPK pathway and does not simply reduce the amount of 
overall ERK that is available to be phosphorylated. In Hh signaling, Gli proteins are proteolytically 
processed into a repressor form that blocks the transcription of Hh target genes (Bangs and 
Anderson, 2017). When the pathway is activated, this proteolytic processing of the Gli protein is 
blocked, allowing for the activator form of Gli to activate the transcription of Hh target genes 
(Bangs and Anderson, 2017). For the Gli2 repressor probe, the cells overexpressing Ttc39c showed 
significantly higher amounts of Gli2 repressor at later differentiation time points when compared 
to the control cells (Fig. 21B). This suggests the overexpression of Ttc39c also causes a decrease 
in Hh signaling due to an increase in the repressor form of Gli2 in vitro.  
To confirm these observations, reporter assays were performed to quantify the effects of Ttc39c 
overexpression on both of these signaling pathways. For MAPK signaling, an AP-1 reporter 
construct was transfected into C2C12 myoblasts with and without Ttc39c overexpression and its 
activity was measured over a 7 day time course. In accordance with the Western blot data, AP-1 
reporter activity was significantly lower in the cells overexpressing Ttc39c (Fig. 22B). For Hh 
signaling, a Gli reporter construct was transfected into C2C12 myoblasts and its activity was also 
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measured over 7 days of differentiation. The results of the reporter assays confirmed the Western 
blot data, by showing significantly reduced reporter activity in the cells overexpressing Ttc39c 
(Fig. 22C). Taking the Western blot and reporter data together, it is apparent Ttc39c 
overexpression inhibits myogenesis by attenuating signaling pathways required for proper muscle 
cell differentiation. 
 
Knockdown of Ttc39c inhibits myoblast differentiation.  
After observing that overexpression of Ttc39c inhibits myoblast differentiation and attenuates 
MAPK and Hh signaling in muscle cells, we next wanted to determine how knocking down the 
expression of Ttc39c via an siRNA would affect these same processes. Interestingly, as with the 
overexpression experiments, C2C12 myoblast differentiation was significantly inhibited when 
Ttc39c was repressed. Compared to the control cells, MyHC and myogenin expression levels were 
dramatically lower (Fig. 25). We confirmed that the observed reduction in MRF expression was 
reflected in lower E-box reporter gene activity in C2C12 cells with Ttc39c knocked down compared 
to control cells. As with the overexpression cells, the reporter activity was dramatically lower 
compared to the control cells, suggesting that aberrant Ttc39c expression (i.e. too high or too low) 
negatively affects muscle cell differentiation (Fig. 26). 
 
Knockdown of Ttc39c attenuates MAPK and Hh signaling in myoblasts. 
As with Ttc39c overexpression, the effect that knocking down Ttc39c has on the MAPK and Hh 
signaling pathways was evaluated. As with the overexpression cells, p-ERK was practically absent 
when Ttc39c was repressed, while overall ERK levels remained constant, again suggesting that 
activation of the MAPK pathway is inhibited in response to aberrant Ttc39c expression levels (Fig. 
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27). Interestingly, lower levels of Gli2 repressor were observed in the Ttc39c knockdown cells, 
which is the opposite of what was observed with overexpression of Ttc93c in muscle cells (Fig. 
27). This observation suggests that repressing Ttc39c could possibly increase Hh signaling by 
reducing the repressor form of Gli2. 
Finally, we evaluated the effects of Ttc39c knockdown on MAPK and Hh signaling by transfecting 
the AP-1 reporter or Gli Reporter into C2C12 myoblasts with and without Ttc39c repression and 
measured reporter activity over a 5 day time course. Reporter activity for both constructs was 
dramatically lower in the knockdown cells, even more so than what was observed in the Ttc39c 
overexpression cells (Fig. 28B-C). While this supports the Western blot data for MAPK signaling, 
lower Hh signaling seems counterintuitive in light of the lower levels of repressor Gli2 on the 
Western blot in cells with Ttc39c repression. A possible explanation is the lack of Gli2 protein in 
the cells could be indicative of a general lack of expression of proteins involved in Hh signaling. 
Less components of the signaling pathway are present, thus there is less overall Gli2 available to 
be proteolytically processed, resulting in dramatically lower Hh signaling observed in the reporter 
assays. To fully elucidate this process, further investigation will be required.  As with the Ttc39c 
overexpression data, these findings suggest that repressing Ttc39c inhibits myogenesis by 
dramatically attenuating signaling pathways required for proper muscle cell differentiation. The 
Ttc39c overexpression and knockdown data strongly support the hypothesis that Ttc39c has a 
specific and relatively narrow window of function and proper and highly regulated expression is 





Ttc39c associates with transport complexes and cytoskeletal elements of the primary cilium. 
This study suggests proper Ttc39c expression is critical for myogenesis, as aberrant Ttc39c 
expression results in decreased Hh and MAPK signaling pathway activity (Fig. 21, 22, 27, and 
28). This decrease in signaling results in a decrease in MRF expression, which then leads to a 
decrease in the expression of genes required for myogenesis (Fig. 19, 20, 25, and 26). While the 
exact functional mechanism of Ttc39c remains to be elucidated, previous studies suggest Ttc39c 
carries out its function within the primary cilium. A recent study by Xu et al. showed Ttc39c to 
be critical for proper cilia formation and function in zebrafish (Xu et al., 2015). While 
differentiated myotubes lack cilia, myoblasts possess primary cilia, which are structures that 
have been shown to be critical for proper myogenesis (Fu et al., 2014).  
 
Xu et al. further observed via co-immunoprecipitation that Ttc39c weakly associated with 
IFT139 and IFT144, proteins belonging to the IFT-A complex in primary cilia (Xu et al., 2015). 
Interestingly, Xu et al. did not observe Ttc39c association with proteins from the IFT-B complex, 
suggesting it associates only with IFT-A complex proteins and may participate exclusively in 
retrograde transport within the primary cilium (Xu et al., 2015). Data presented in this study 
shows an increase in IFT144 protein levels but not IFT88 when Ttc39c is overexpressed (Fig. 
23). This further implicates Ttc39c in primary cilia formation and function via its connection 
with the IFT-A complex, but not IFT-B. If the overexpression of Ttc39c is affecting proper 
transport of signaling components within the cilium, this could explain its significant impact on 
cell signaling and muscle cell differentiation. Whether Ttc39c acts as a scaffolding protein for 
the IFT-A complex via its TPR domains requires further investigation. The association of Ttc39c 
with transport complexes involved with microtubules is intriguing considering the data presented 
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in this study shows Ttc39c appears to localize with the cell cytoskeleton (Fig. 18). This apparent 
association of Ttc39c with the centrosome and microtubules is of interest, as the basal body of 
the primary cilium is derived from the mother centriole of the centrosome and is responsible for 
forming the axoneme of the cilium (Prevo, et al., 2017). This could explain the aberrant 
microtubule growth and improper primary cilium formation, but the exact mechanism remains 
unclear. While further investigation is required to confirm the associations with the centrosome 
and elucidate what is causing the aberrant protrusions, this is yet more evidence suggesting 
Ttc39c is associated with cytoskeletal elements that comprise primary cilia. 
 
Ttc39c expression overlaps with the assembly and disassembly of primary cilia in muscle cells. 
A 2014 study by Fu et al. looking at primary cilia and Hh signaling in myoblasts suggests that 
primary cilia formation occurs within early differentiation of myoblasts and that the cilia are 
subsequently disassembled as differentiation progresses (Fu et al., 2014). This study found that 
cilia formation peaked at around 24 hours into the differentiation process but were then 
disassembled and greatly diminished by 48 hours into differentiation (Fu et al., 2014). The 
investigators also observed that disassembly of the primary cilia was a precursor to myoblast 
fusion, as most multi-nucleated muscle cells lacked primary cilia by 48 hours into differentiation, 
while the increase in MyHC expression was usually observed shortly thereafter (Fu et al., 2014). 
This temporally overlaps with data presented in this study showing Ttc39c mRNA and protein 
expression peaks in early differentiation but decreases as differentiation continues (Fig.7C and 
9). Taken in context with previous findings showing that Ttc39c is critical for cilia formation and 
function, our data suggests that the temporal overlap in Ttc39c expression and primary cilia 
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formation is more than coincidental, and Ttc39c likely functions within the primary cilium of 
developing muscle cells (Fu et al., 2014; Xu et al., 2015). 
 
Ttc39c may affect cell signaling during myogenesis via the primary cilium. 
Ttc39c involvement with primary cilia formation and function is further supported by data 
presented in this study showing both the overexpression and repression of Ttc39c attenuates both 
myogenesis and cell signaling pathways (Fig. 19-22, 25-28). Hh and MAPK signaling is critical 
for proper myogenesis and both pathways require primary cilia for proper signal transduction 
(Bangs and Anderson, 2017; Christensen, et al., 2012). This study suggests aberrant Ttc39c 
expression results in attenuated Hh and MAPK signaling via improper primary cilia formation, 
which leads to a decrease in MRF expression. This decrease in MRF expression in turn leads to a 
decrease in the expression of genes required for myogenesis, thus resulting in the inhibition of 
skeletal muscle cell differentiation.  
 
How Ttc39c and primary cilia function within skeletal muscle atrophy has yet to be studied. 
Based on data presented in this study, the induction of Ttc39c expression during neurogenic 
muscle atrophy requires the expression of MuRF1, a major regulator of skeletal muscle atrophy 
(Fig. 6). Considering proper myogenesis requires the formation and function of primary cilia, 
this suggests MuRF1 is necessary for the expression of genes that are involved in the assembly 
and function of primary cilia. The presence of primary cilia then facilitates the cell signaling 
required for proper myogenesis. These findings are intriguing and suggest that induction of 
Ttc39c is likely the result of increased primary cilia formation in differentiating myoblasts that 
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arise from activated satellite cell division in response to muscle wasting in an attempt to repair 
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